Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

629 ARTÍCULOS , VIENDO DEL 331 AL 345

Multi-mechanical waves against Alzheimer's disease pathology: a systematic review

Monteiro F, Sotiropoulos I, Carvalho Ó, Sousa N, Silva FS.

Transl Neurodegener. 2021 Sep 24;10(1):36. doi: 10.1186/s40035-021-00256-z.

Immune function, cortisol, and cognitive decline & dementia in an aging latino population

Stebbins RC, Edwards JK, Plassman BL, Yang YC, Noppert GA, Haan M, Aiello AE.

Psychoneuroendocrinology. 2021 Nov;133:105414. doi: 10.1016/j.psyneuen.2021.105414. Epub 2021 Sep 15.

Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review

Puga AM, Ruperto M, Samaniego-Vaesken ML, Montero-Bravo A, Partearroyo T, Varela-Moreiras G.

Nutrients. 2021 Aug 26;13(9):2966. doi: 10.3390/nu13092966.

Dose-Response Meta-Analysis on Tooth Loss With the Risk of Cognitive Impairment and Dementia

Qi X, Zhu Z, Plassman BL, Wu B.

J Am Med Dir Assoc. 2021 Oct;22(10):2039-2045. doi: 10.1016/j.jamda.2021.05.009. Epub 2021 Jul 8.

Driving and Alzheimer's dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist's role

Stamatelos P, Economou A, Stefanis L, Yannis G, Papageorgiou SG.

Neurol Sci. 2021 Dec;42(12):4953-4963. doi: 10.1007/s10072-021-05610-7. Epub 2021 Sep 28.

Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review

Grueso S, Viejo-Sobera R.

Alzheimers Res Ther. 2021 Sep 28;13(1):162. doi: 10.1186/s13195-021-00900-w.

Editorial: How Will Aducanumab Approval Impact AD Research?

Weiner MW, Aisen PS, Beckett LA, Green RC, Jagust W, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ.

J Prev Alzheimers Dis. 2021;8(4):391-392. doi: 10.14283/jpad.2021.46.

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

Lowe SL, Duggan Evans C, Shcherbinin S, Cheng YJ, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR.

J Prev Alzheimers Dis. 2021;8(4):414-424. doi: 10.14283/jpad.2021.56.

Editorial: Alzheimer's Disease Research in Japan: A Short History, Current Status and Future Perspectives toward Prevention

Iwatsubo T, Niimi Y, Akiyama H.

J Prev Alzheimers Dis. 2021;8(4):462-464. doi: 10.14283/jpad.2021.38.

The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial

Sugimoto T, Sakurai T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, Kinoshita F, Kuzuya M, Lee S, Matsuo K, Michikawa M, Ogawa S, Otsuka R, Sato K, Shimada H, Suzuki H, Suzuki H, Takechi H, Takeda S, Umegaki H, Wakayama S, Arai H.

J Prev Alzheimers Dis. 2021;8(4):465-476. doi: 10.14283/jpad.2021.29.

Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives

Usman MB, Bhardwaj S, Roychoudhury S, Kumar D, Alexiou A, Kumar P, Ambasta RK, Prasher P, Shukla S, Upadhye V, Khan FA, Awasthi R, Shastri MD, Singh SK, Gupta G, Chellappan DK, Dua K, Jha SK, Ruokolainen J, Kesari KK, Ojha S, Jha NK.

J Prev Alzheimers Dis. 2021;8(4):534-551. doi: 10.14283/jpad.2021.52.

Does early-stage intervention improve caregiver well-being or their ability to provide care to persons with mild dementia or mild cognitive impairment? A systematic review and meta-analysis

Bayly M, Morgan D, Elliot V, Kosteniuk J, Froehlich Chow A, Peacock S, O'Connell ME.

Psychol Aging. 2021 Nov;36(7):834-854. doi: 10.1037/pag0000642. Epub 2021 Sep 30.

A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan

Washida K, Kitajima E, Tanaka T, Ikeda S, Chiba T, Noda K, Yoshimoto T, Fukuma K, Saito S, Ihara M.

J Alzheimers Dis. 2021;84(3):1103-1114. doi: 10.3233/JAD-215006.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias